Rising mortality and post-COVID shifts due to stroke in adults with dyslipidemia in the U.S. from 1999 to 2023: analysis of the CDC WONDER database

Stroke-related mortality among individuals with dyslipidemia has risen markedly in the U.S., despite the overall national decline in stroke mortality. This likely reflects the increasing prevalence of metabolic risk factors, an aging population, genetic predisposition, and inadequate lipid management in high-risk groups.